Company Information

    SeqOnce Biosciences Inc was founded on February 2014. The company is based in Pasadena, CA, USA . The number of employees in SeqOnce Biosciences Inc is less than 10. Next generation sequencing - sample preparation technologies

    Here is how SeqOnce Biosciences Inc describes itself: "The fastest, simplest library prep kit on the market. Faster results and higher throughput using a novel, simple procedure."
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          SeqOnce Biosciences Inc has received 2 rounds of venture funding. The total funding amount is around $1.2M.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        SeqOnce Biosciences Inc - Blog

                          • SeqOnce Biosciences Announces AzureSeq RT-qPCR Assay to Detect SARS-CoV-2 E484K Variant of Concern

                          • New assay detects Brazilian and South African SARS-CoV-2 variant faster than sequencing, screens more samples Pasadena, CA., Mar 8, 2021- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 E484K variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR E484K kit uses a [...]The post SeqOnce Biosciences Announces AzureSeq RT-qPCR Assay to Detect SARS-CoV-2 E484K Variant of Concern appeared first on SeqOnce.
                          • SeqOnce BioSciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant

                          • Assay quickly identifies mutation found in U.K. SARS-CoV-2 N501Y Pasadena, CA., Jan 27, 2021- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid [...]The post SeqOnce BioSciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant appeared first on SeqOnce.
                          • SeqOnce Biosciences Launches AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR Kit

                          • Pasadena, CA., July 14, 2020 – SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of novel coronavirus, SARS-CoV-2. This kit allows for fast turnaround time for customization and delivers a reliable, highly sensitive one-step multiplex RT-qPCR solution for rapid testing. AzureSeq targets two regions of [...]The post SeqOnce Biosciences Launches AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR Kit appeared first on SeqOnce.
                          • RhinoSeq ASHG Poster 2019 – A 12 Minute, Single Tube, Nanogram Input Library Prep
 for Multiple NGS Applications

                          • Next Generation Sequencing (NGS) library construction is a workflow bottleneck. The processes of library construction for DNA and RNA sequencing are complex, error prone, costly, and in general are me consuming. Current commercial products offer multistep, multi-hour sample processing that can be cost and labor prohibitive. These issues have created a demand for a simple, rapid, and cost-effective library construction products that offer users [...]The post RhinoSeq ASHG Poster 2019 – A 12 Minute, Single Tube, Nanogram Input Library Prep
 for Multiple NGS Applications appeared first on SeqOnce.
                          • Understanding NGS Library Complexity: Sources of Sequencing Errors & Limits of Detection

                          • Next-generation sequencing is, by definition, “massively parallel.” While the first 454/Curagen GS20 systems yielded a million reads per run, the latest sequencing platforms from Illumina, (NovaSeq 6000 running their highest-capacity S4 flowcell), yields 10,000X the number (i.e. 10 billion reads) per sequencing run. Applications such as somatic mutation detection in cancer samples require increasingly greater [...]The post Understanding NGS Library Complexity: Sources of Sequencing Errors & Limits of Detection appeared first on SeqOnce.
                          • Introducing the SeqOnce and Done Blog and the Team Behind the Technology

                          • SeqOnce is a company founded upon the idea that steps involved in Next Generation Sequencing (NGS) need to be both streamlined and simplified. Having developed and launched the first product, RhinoSeq, NGS library preparation time has been reduced some 75% with only one transfer and cleanup step (compared to three or more transfer steps with [...]The post Introducing the SeqOnce and Done Blog and the Team Behind the Technology appeared first on SeqOnce.

                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *